Skip to content
Home
About
About Project ECHO®
FAQ
Apply to ECHO COE
Contact
ECHO Research
ECHO Care of the Elderly Team
Provincial ECHO
About
Apply to ECHO COE
Didactic Curriculum
2023
2022
2021
2020
2019
2018
National ECHO
Apply to National ECHO
GEMH Didactic Curriculum
GEMH 2021
GEMH 2023
GEMH Clinical Resources
Long Term Care – COVID-19
LTC COVID-19 Curriculum
LTC COVID-19 Resources
My Account
Login
Search for:
Search
CCCDTD5: Clinical role of neuroimaging and liquid biomarkers in patients with cognitive impairment
Home
GEMH
CCCDTD5: Clinical role of neuroimaging and liquid biomarkers in patients with cognitive impairment
How Can We Help?
Search
< All Topics
You are here:
Main
Articles By Topic (6 weeks)
Session 04: Screening, Assessment & Diagnosis of Dementia
CCCDTD5: Clinical role of neuroimaging and liquid biomarkers in patients with cognitive impairment
Print
CCCDTD5: Clinical role of neuroimaging and liquid biomarkers in patients with cognitive impairment
Posted
March 24, 2021
Updated
April 16, 2021
By
echo_wpbaycrest_admin
CCCDTD5- Clinical role of neuroimaging and liquid biomarkers in patients with cognitive impairment
Table of Contents